| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000010303 |
| Receipt No. | R000012058 |
| Official scientific title of the study | Research of Patient satisfaction after Breast conserving therapy |
| Date of disclosure of the study information | 2013/03/22 |
| Last modified on | 2016/09/24 (Ver. 7) |
| Basic information | ||
| Official scientific title of the study | Research of Patient satisfaction after Breast conserving therapy | |
| Title of the study (Brief title) | Research of Patient satisfaction after Breast conserving therapy | |
| Region |
|
|
| Condition | ||
| Condition | Breast cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To clarify the extent of preserved breast deformation and differences in patient satisfaction and investigate the clinical factors affecting breast deformation.
|
| Basic objectives2 | Others |
| Basic objectives -Others | To clarify the extent of preserved breast deformation and differences in patient satisfaction and investigate the clinical factors affecting breast deformation. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Patient satisfaction |
| Key secondary outcomes | Evaluation of deformation after breast conserving therapy |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Patients scheduled for outpatient follow-up examination at one, two, and three years after undergoing breast-conserving therapy at the Cancer Institute Hospital of JFCR were enrolled.
|
|||
| Key exclusion criteria | Patients less than one year after surgery.
Cases of bilateral breast cancer. Cases of ipsilateral metachronous breast cancer. Cases of local recurrence and distant recurrence. The cases which are included past surgical wound in the shooting range. Cases of bilateral breast cancer. Patients who underwent mastectomy after breast-conserving surgery. |
|||
| Target sample size | 230 | |||
| Research contact person | |
| Name of lead principal investigator | Yoshinari Goto |
| Organization | Cancer Institute Hospital, Japanese Foundation for Cancer Research |
| Division name | Breast Oncology Center |
| Address | 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550 Japan |
| TEL | 03-3520-0111 |
| yoshinari510@mail.goo.ne.jp | |
| Public contact | |
| Name of contact person | Yoshinari Goto |
| Organization | Cancer Institute Hospital, Japanese Foundation for Cancer Research |
| Division name | Breast Oncology Center |
| Address | 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550 Japan |
| TEL | 03-3520-0111 |
| Homepage URL | |
| yoshinari510@mail.goo.ne.jp | |
| Sponsor | |
| Institute | Cancer Institute Hospital, Japanese Foundation for Cancer Research. Breast Oncology Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Cancer Institute Hospital, Japanese Foundation for Cancer Research. Breast Oncology Center |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Patient satisfaction was assessed on the basis of the following four levels of satisfaction:
1. Satisfied 2. Somewhat satisfied 3. Somewhat unsatisfied 4. Unsatisfied We evaluated each of the following items while assessing satisfaction and cosmetic appearance: Age disease location Resection volume (weight) Whether or not radiotherapy was administered Whether or not chemotherapy was administered Whether or not hormone therapy was administered Disease stage Cosmetic appearance was scored on the basis of the following parameters that conformed to the evaluation of postoperative cosmetic outcome by the Japanese Breast Cancer Society Sawai group: 1. Breast size: 2 (almost identical), 1 (minor difference), and 0 (considerable difference) 2. Breast shape: 2 (almost identical), 1 (minor difference), and 0 (considerable difference) 3. Scar: 2 (Unnoticeable) and 1 (slightly noticeable) 4. Breast firmness: 2 (soft), 1 (somewhat firm), and 0 (fairly firm) 5. Nipple and areola size/shape: 1 (no difference between left and right) and 0 (difference between left and right) 6. Nipple and areola color tone: 1 (no difference between left and right) and 0 (difference between left and right) 7. Nipple position (difference between left and right with regard to distance from sternal incisures): 1 (<2 cm) and 0 (greater than or equal to 2 cm) 8. Position of the maximum descent point of the breast (difference in height between left and right): 1 (<2 cm) and 0 (greater than or equal to 2 cm) 9. Comprehensive evaluation: 11-12 points, excellent; 8-10 points, good; 5-7 points, fair; and 0-4 points, poor |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000012058 |